NUTRA PHARMA CORP. (NPHC) Net margin 2016–2025
NUTRA PHARMA CORP. (NPHC) net profit margin by fiscal year — reported net income divided by reported revenue.
-794.8%FY2025 · since FY2016: -2047.8% → -794.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -794.8% | -272.8 pp |
| FY2024 | -522.0% | +155.8 pp |
| FY2023 | -677.8% | -6286.1 pp |
| FY2022 | 5608.3% | +19007.3 pp |
| FY2021 | -13399.0% | -11916.9 pp |
| FY2020 | -1482.1% | +4831.9 pp |
| FY2019 | -6314.1% | -3339.5 pp |
| FY2018 | -2974.6% | +355.5 pp |
| FY2017 | -3330.1% | -1282.3 pp |
| FY2016 | -2047.8% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice